Results 201 to 210 of about 2,688,199 (290)
Generative adversarial network-based super-resolution reconstruction of remote sensing images. [PDF]
Wang L, Liu L, Yu Q, Yuan D.
europepmc +1 more source
A large‐scale multicenter serum metabolomics study (13 centers, n = 2,149) identified a 9‐metabolite + AFP diagnostic signature for liver cancer (AUC = 0.93). Among the signature, nicotinamide (NAM) was validated as an oncometabolite: NAM enhances NAD+ synthesis, activating SIRT1 to deacetylate and stabilize HIF1α, thereby driving glycolysis, MAPK ...
Yongjie Xu +13 more
wiley +1 more source
Letter to the Editor: Three questions to be answered when evaluating a super obese patient for urgent liver transplant. [PDF]
Baggio L +8 more
europepmc +1 more source
Vaccination promotes cellular infiltration into primary lesions and effectively inhibits T. pallidum dissemination to distal organs. Notably, transfer of lesion tissue from immunized animals fails to establish infection in naive recipients, confirming specific protective immunity.
Yinbo Jiang +4 more
wiley +1 more source
Frequency-Geometry-Guided Network for Depth Map Super-Resolution. [PDF]
Feng Z, Zhang C.
europepmc +1 more source
Under pathological stimulation, NCOA4 in macrophages interacts with STAT1 to promote CH25H transcription. The subsequent increase in 25‐HC production activates macrophages, triggers inflammatory responses and ferroptosis, and accelerates the progression of AAA.
Zhinan Wu +9 more
wiley +1 more source
Scale-Adaptive High-Resolution Imaging Using a Rotating-Prism-Guided Variable-Boresight Camera. [PDF]
Deng Z, Li A, Zhao X, Lai Y, Jin J.
europepmc +1 more source
CD112 Lactylation Drives Dual Immune Evasion From CD8+ T Cells and NK Cells
AARS2 functions as an intracellular lactate sensor and lactyltransferase, catalyzing CD112 K412 lactylation to block ubiquitination‐dependent degradation and stabilize CD112. This pathway suppresses CD8+ T‐cell and NK‐cell cytotoxicity, enabling dual immune evasion.
Zhuoshuo Xu +6 more
wiley +1 more source
The AI-POCUS Revolution is Here-Are Family Physicians and Our Health Systems Ready? [PDF]
Szkwarko D, Elias H, Ramos M, Bergman K.
europepmc +1 more source
Parkinson's disease currently has no disease‐modifying therapies. In Caenorhabditis elegans, Escherichia coli E8 alleviates α‐synuclein‐provoked PD‐related defects through its bioactive metabolite 1‐ALPP, which combats PD by triggering AMPK/mTOR/HLH‐30‐dependent autophagy and suppressing α‐synuclein LLPS‐mediated fibrillization.
Mingqin Qu +12 more
wiley +1 more source

